SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Apr. 30, 2019

PHARMACYTE BIOTECH, INC.

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

Years Ended April 30, 2019 and 2018

Description

Balance at
Beginning of
Year

Additions
Charged to
Costs and
Expenses

Charged to
Other
Accounts

Deductions

Balance at
End of Year

Reserve Deducted in the Balance Sheets from the Asset to which it applies:

Allowance for Deferred Tax Assets

Year ended April 30, 2019

13,235,601

–

952,170

–

14,187,771

Year ended April 30, 2018

11,521,295

–

1,714,306

–

13,235,601